Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Brian Tomlinson, Elaine Chow, Paul Chan & Christopher Wai Kei Lam. (2021) An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1353-1361.
Read now
Read now
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok & Christopher Wai Kei Lam. (2021) Managing dyslipidemia in patients with Type 2 diabetes. Expert Opinion on Pharmacotherapy 22:16, pages 2221-2234.
Read now
Read now
Amir Mohammad Malvandi, Laura Canclini, Anxhela Alliaj, Paolo Magni, Alberto Zambon & Alberico Luigi Catapano. (2020) Progress and prospects of biological approaches targeting PCSK9 for cholesterol-lowering, from molecular mechanism to clinical efficacy. Expert Opinion on Biological Therapy 20:12, pages 1477-1489.
Read now
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang & Christopher Wai Kei Lam. (2020) Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy. Expert Opinion on Pharmacotherapy 21:17, pages 2137-2151.
Read now
Read now
Brian Tomlinson, Paul Chan & Christopher Wai Kei Lam. (2020) Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes. Expert Review of Endocrinology & Metabolism 15:3, pages 147-157.
Read now
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang, Zhongmin Liu & Christopher Wai Kei Lam. (2020) Pharmacokinetics of current and emerging treatments for hypercholesterolemia. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 371-385.
Read now
Read now
Eli M. Roth. (2018) A safety evaluation of evolocumab. Expert Opinion on Drug Safety 17:1, pages 99-106.
Read now
Read now
Articles from other publishers (14)
Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, Piotr Fularski, Ewelina Młynarska, Ewa Radzioch, Jacek Rysz & Beata Franczyk. (2023) Advances in Treatment of Dyslipidemia. International Journal of Molecular Sciences 24:17, pages 13288.
Crossref
Crossref
Michele Bellino, Gennaro Galasso, Angelo Silverio, Michele Tedeschi, Ciro Formisano, Stefano Romei, Luca Esposito, Francesco Paolo Cancro, Maria Giovanna Vassallo, Giulio Accarino, Monica Verdoia, Francesca Maria Di Muro, Carmine Vecchione & Giuseppe De Luca. (2023) Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand?. Journal of Clinical Medicine 12:8, pages 2922.
Crossref
Crossref
Saverio Muscoli, Mihaela Ifrim, Massimo Russo, Francesco Candido, Angela Sanseviero, Marialucia Milite, Marco Di Luozzo, Massimo Marchei & Giuseppe Massimo Sangiorgi. (2022) Current Options and Future Perspectives in the Treatment of Dyslipidemia. Journal of Clinical Medicine 11:16, pages 4716.
Crossref
Crossref
D. Yu. Sedykh, V. V. Kashtalap, O. N. Khryachkova, T. S. Petrova & O. L. Barbarash. (2022) Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors. Russian Journal of Cardiology 27:6, pages 5030.
Crossref
Crossref
Nolwenn Tessier, Fatma Moawad, Nada Amri, Davide Brambilla & Catherine Martel. (2021) Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine. Pharmaceutics 13:8, pages 1200.
Crossref
Crossref
Piotr Pęczek, Mateusz Leśniewski, Tomasz Mazurek, Lukasz Szarpak, Krzysztof J. Filipiak & Aleksandra Gąsecka. (2021) Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia. Life 11:6, pages 466.
Crossref
Crossref
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok & Christopher Wai Kei Lam. (2021) Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia. Endocrinology and Metabolism 36:2, pages 279-295.
Crossref
Crossref
A. O. Bueverov, P. O. Bogomolov, A. A. Kucherov & V. E. Syutkin. (2021) Alirokumab in the practice of a multidisciplinary outpatient hospital: results of an open, noncomparative prospective study. Sechenov Medical Journal 11:4, pages 15-22.
Crossref
Crossref
María Aguilar-Ballester, Gema Hurtado-Genovés, Alida Taberner-Cortés, Andrea Herrero-Cervera, Sergio Martínez-Hervás & Herminia González-Navarro. (2021) Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia. International Journal of Molecular Sciences 22:2, pages 660.
Crossref
Crossref
Amer A. Alkhatib & Pascale Anglade. (2020) Alirocumab-Induced Hyperlipasemia and Hyperamylasemia. Annals of Pharmacotherapy 54:7, pages 720-721.
Crossref
Crossref
Amand F. Schmidt, Michael V. Holmes, David Preiss, Daniel I. Swerdlow, Spiros Denaxas, Ghazaleh Fatemifar, Rupert Faraway, Chris Finan, Dennis Valentine, Zammy Fairhurst-Hunter, Fernando Pires Hartwig, Bernardo Lessa Horta, Elina Hypponen, Christine Power, Max Moldovan, Erik van Iperen, Kees Hovingh, Ilja Demuth, Kristina Norman, Elisabeth Steinhagen-Thiessen, Juri Demuth, Lars Bertram, Christina M. Lill, Stefan Coassin, Johann Willeit, Stefan Kiechl, Karin Willeit, Dan Mason, John Wright, Richard Morris, Goya Wanamethee, Peter Whincup, Yoav Ben-Shlomo, Stela McLachlan, Jackie F. Price, Mika Kivimaki, Catherine Welch, Adelaida Sanchez-Galvez, Pedro Marques-Vidal, Andrew Nicolaides, Andrie G. Panayiotou, N. Charlotte Onland-Moret, Yvonne T. van der Schouw, Giuseppe Matullo, Giovanni Fiorito, Simonetta Guarrera, Carlotta Sacerdote, Nicholas J. Wareham, Claudia Langenberg, Robert A. Scott, Jian’an Luan, Martin Bobak, Sofia Malyutina, Andrzej Pająk, Ruzena Kubinova, Abdonas Tamosiunas, Hynek Pikhart, Niels Grarup, Oluf Pedersen, Torben Hansen, Allan Linneberg, Tine Jess, Jackie Cooper, Steve E. Humphries, Murray Brilliant, Terrie Kitchner, Hakon Hakonarson, David S. Carrell, Catherine A. McCarty, Kirchner H. Lester, Eric B. Larson, David R. Crosslin, Mariza de Andrade, Dan M. Roden, Joshua C. Denny, Cara Carty, Stephen Hancock, John Attia, Elizabeth Holliday, Rodney Scott, Peter Schofield, Martin O’Donnell, Salim Yusuf, Michael Chong, Guillaume Pare, Pim van der Harst, M. Abdullah Said, Ruben N. Eppinga, Niek Verweij, Harold Snieder, Tim Christen, D. O. Mook-Kanamori, Stefan Gustafsson, Lars Lind, Erik Ingelsson, Raha Pazoki, Oscar Franco, Albert Hofman, Andre Uitterlinden, Abbas Dehghan, Alexander Teumer, Sebastian Baumeister, Marcus Dörr, Markus M. Lerch, Uwe Völker, Henry Völzke, Joey Ward, Jill P. Pell, Tom Meade, Ingrid E. Christophersen, Anke H. Maitland-van der Zee, Ekaterina V. Baranova, Robin Young, Ian Ford, Archie Campbell, Sandosh Padmanabhan, Michiel L. Bots, Diederick E. Grobbee, Philippe Froguel, Dorothée Thuillier, Ronan Roussel, Amélie Bonnefond, Bertrand Cariou, Melissa Smart, Yanchun Bao, Meena Kumari, Anubha Mahajan, Jemma C. Hopewell, Sudha Seshadri, Caroline Dale, Rui Providencia E. Costa, Paul M. Ridker, Daniel I. Chasman, Alex P. Reiner, Marylyn D. Ritchie, Leslie A. Lange, Alex J. Cornish, Sara E. Dobbins, Kari Hemminki, Ben Kinnersley, Marc Sanson, Karim Labreche, Matthias Simon, Melissa Bondy, Philip Law, Helen Speedy, James Allan, Ni Li, Molly Went, Niels Weinhold, Gareth Morgan, Pieter Sonneveld, Björn Nilsson, Hartmut Goldschmidt, Amit Sud, Andreas Engert, Markus Hansson, Harry Hemingway, Folkert W. Asselbergs, Riyaz S. Patel, Brendan J. Keating, Naveed Sattar, Richard Houlston, Juan P. Casas & Aroon D. Hingorani. (2019) Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovascular Disorders 19:1.
Crossref
Crossref
Speranza Rubattu & Massimo Volpe. (2019) Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics. International Journal of Molecular Sciences 20:16, pages 3991.
Crossref
Crossref
David M. Ng, John R. Burnett, Damon A. Bell, Robert A. Hegele & Amanda J. Hooper. (2019) Update on the diagnosis, treatment and management of rare genetic lipid disorders. Pathology 51:2, pages 193-201.
Crossref
Crossref
Allison B. ReissNeal ShahDalia MuhieddineJuan ZhenJennifer YudkevichLora J. KasselmanJoshua DeLeon. (2018) PCSK9 in cholesterol metabolism: from bench to bedside. Clinical Science 132:11, pages 1135-1153.
Crossref
Crossref